Top News

Press Release | February 19, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) again urged the U.S. EPA to abandon its ethylene oxide (EtO) risk assessment value for one that is more feasible, based on the best available science and that will not potentially endanger the public health by threatening the availability of needed medical technologies.
Press Release | February 12, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither practical nor is it based on the latest science, and pursuing it could pose an increased risk to public health through supply chain and distribution threats.
Press Release | February 11, 2020
WASHINGTON, D.C. – This week, AdvaMed President and CEO, Scott Whitaker, and AdvaMed CFO and Executive Director of AdvaMed Advance, Jennifer Brearey, co-authored an editorial outlining steps the medical technology industry is taking to cultivate more diverse, more inclusive workplace cultures.

Events

February
24
February 24, 2020 to February 25, 2020
| Irvine, CA
FDA and industry experts are coming together to review the basics of 510(k) submissions. This unique opportunity will help you better understand the FDA perspective on 510(k) submissions, from... Read More
February
26
February 26, 2020 | Irvine, CA
During this interactive workshop, FDA and industry experts will lead you through the regulatory and practical guidelines governing when an investigational device exemption (IDE) is required. Agenda... Read More
February
27
February 27, 2020 | Webinar
On February 27th, from 2:00 – 3:00 PM ET, AdvaMed and Baker Tilly will hold a webinar on Payers’ Perspectives on Value Based Care: What Life Science Companies Should Know. The event will address best... Read More
February
27
February 27, 2020 to February 28, 2020
| Irvine, CA
Completing the set of interactive submissions workshops, industry and FDA experts will lead you through the strategic considerations and practical steps of filing a Premarket Approval. Agenda topics... Read More
March
18
March 18, 2020 | Newport Beach, CA
AdvaMed is excited to announce the inaugural AdvaMed Accelerate MedTech Summit on March 18 in Newport Beach, CA. This one-day program will convene entrepreneurs and other small-company leaders,... Read More

Industry News

BOSTON and SYDNEY — 28 January 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the first patient in the United States (U.S.) STEP-1 clinical trial has been enrolled at Michigan Medicine in Ann Arbor, Michigan. Michigan Medicine is one of five clinical study sites for the STEP-1 trial; the site is led by principal investigator Allison R. Schulman M.D., M.P.H., assistant professor of...
SAN JOSE, Calif., December 3, 2019 — Venclose Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease today announced it has closed a Series C funding led by Ally Bridge Group (ABG). ABG is a global life science-focused group with a successful investment record globally in supporting high-growth innovative life science companies. “Securing this financing further confirms continued investor confidence in Venclose’s...
Where Women Work
Prime employers for women BD and Medtronic both attended the prestigious MedTech Conference and addressed industry delegates. The conference saw more than 3,300 of the world’s top medical technology executives gather in Boston, USA, for educational programming, valuable networking and business development opportunities. Positioning corporate diversity and inclusion for success BD’s VP of Inclusion & Diversity Johnel Evans joined other executive leaders on a panel discussing positioning...
Eight New York members of Congress are urging House and Senate leadership to address the Affordable Care Act's medical device tax before the end of the year.  The bipartisan group of lawmakers want to repeal or delay the excise tax, which was included in the 2010 health care law as a revenue generator. The 2.3% tax on the sale of medical devices took effect in 2013, but Congress acted in 2015 to impose a two-year moratorium. In 2017, Congress extended the moratorium on the medical device tax...
NEW YORK, Sept. 18, 2019 /PRNewswire/ -- TEAMFund ("Transforming Equity and Access for MedTech") -- a novel hybrid organization combining a Non-Profit with a For-Profit Fund investing in medical technology companies that improve patient access in low-resource settings -- today announced the Final Closing of its $30mm Inaugural Fund. The Fund is led by longtime MedTech investor, Yousuf Mazhar and Tim Ring, former Chairman and CEO of C.R. Bard. TEAMFund was the inspiration of Ms. Kathryn Gleason...

Twitter Feed

February 20, 2020 - 9:17am
Want to learn more about where investment is heading? Join us on March 18 in Newport Beach, California to… https://t.co/5TtUEwoJ5C
February 20, 2020 - 9:08am
What should digital companies know going into 2020? and share their expertise. https://t.co/alYHNyyQWC